Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bone Evaluation in HIV-positive women over 40 who Switch from TDF + 3TC/FTC + NNRTI to Triumeq

Next Previous
X
Search
Trial Profile

Bone Evaluation in HIV-positive women over 40 who Switch from TDF + 3TC/FTC + NNRTI to Triumeq

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abacavir/dolutegravir/lamivudine (Primary) ; Efavirenz; Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate; Emtricitabine/tenofovir disoproxil fumarate; Etravirine; Lamivudine; Nevirapine; Rilpivirine; Tenofovir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms BESTT women's

    • Most Recent Events

    • 01 Apr 2022 Results assessing bone mineral density, kidney function and participant-reported outcome measures in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG, published in the HIV Medicine
    • 11 Mar 2020 Status changed from recruiting to completed as per results presented at the 27th Conference on Retroviruses and Opportunistic Infections
    • 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top